Pharmafile Logo
Pharmafocus logo
Advanced Search

Johnson and Johnson

Showing 13 posts of 28 posts found.

Janssen sales follow J&J’s downward trend

July 15, 2015
Sales and Marketing J&J, JJ, Johnson & Johnson, Johnson and Johnson, financial results, olysio

Strong sales of its new hepatitis C treatment Olysio were not enough to stop a slump in profits at J&J’s …

News
Google image

J&J and Google partner to build surgical robots

March 30, 2015
Medical Communications, Sales and Marketing Biogen, Ethicon, J&J, JJ, Johnson and Johnson, MS, google, robots

The medical device subsidiary of Johnson & Johnson Ethicon is to collaborate with Google to build surgical robots and perform …

News
Abbbie image

AbbVie buys Pharmacyclics in $21 billion deal

March 5, 2015
Sales and Marketing AbbVie, Humira, Johnson and Johnson, Pharmacyclics, adalimumab, imbruvica

AbbVie has secured Californian biotech Pharmacyclics and beat Johnson & Johnson to gain control of blockbuster blood cancer therapy Imbruvica in …

News
yana_ignatova

J&J appoints head of marketing in northern Europe

October 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Johnson and Johnson, yana Ignatova

Johnson & Johnson has appointed Yana Ignatova to the position of head of marketing for its northern Europe division. Reporting …

Appointment
J&J image

J&J completes $4 billion OCD sale

July 2, 2014
Sales and Marketing J&J, JJ, Johnson and Johnson, Ortho-Clinical Diagnostics, carlyle, ocd

Johnson & Johnson has sold its Ortho-Clinical Diagnostics (OCD) business to private equity investor The Carlyle Group for ‘approximately $4 …

News
Janssen image

Women in the pharma industry

September 3, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Johnson and Johnson, adams, women

In the past pharma has been accused of being too male-orientated in both the laboratory and the boardroom. The idea …

Feature
janssen image

Janssen outlines pipeline ambitions

May 24, 2013
Research and Development, Sales and Marketing Janssen, Johnson and Johnson, pipeline

Janssen has outlined plans to submit ‘more than ten’ new product filings worldwide in the next four years, along with …

News

Smoke and fire in J&J Code breach

August 15, 2012
Sales and Marketing Champix, J&J, JJ, Johnson and Johnson, PMCPA, Pfizer

Johnson & Johnson has been censured for breaking the ABPI Code of Practice in printed information about its smoking cessation …

News

TBA contamination prompts Topamax recall

April 18, 2011
Manufacturing and Production Johnson and Johnson, recalls

Another Johnson & Johnson business unit has decided to recall medicines because of a mouldy smell thought to be caused …

News

J&J charged with US manufacturing violations

March 15, 2011
Manufacturing and Production J&J, JJ, Johnson and Johnson, McNeil Consumer Healthcare, McNeil Fort Washington, McNeil recall, Motrin recall, manufacturing compliance, pharma manufacturing, recalls

Johnson & Johnson subsidiary McNeil Consumer Healthcare has been officially charged with manufacturing and distributing drugs in violation of federal …

News
Abbott's Humira (adalimumab)

Abbott wins $1.7bn Humira case

February 24, 2011
Sales and Marketing Abbott, Abbott Laboratories, Centocor, Johnson and Johnson, Remicade, Simponi, TNF, golimumab, infliximab, rheumatoid arthritis

Abbott has been saved from paying Johnson & Johnson $1.7 billion after a US appeals court quashed a patent dispute …

News

J&J hepatitis C drug begins phase III trials

February 23, 2011
Research and Development J&J, JJ, Johnson and Johnson, TMC435, Tibotec, hepatitis, hepatitis C

Johnson & Johnson has begun late stage trials of hepatitis C drug TMC435 as a first line treatment for the …

News

J&J posts negative growth as pharma sales stall

January 26, 2011
Sales and Marketing 2010 pharma results, J&J, JJ, Johnson and Johnson, Remicade, Risperdal Consta

Falling fourth quarter sales of Risperdal Consta and Remicade capped a year to forget for Johnson and Johnson. The company’s …

News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026